As US probes possible link between immunization and mostly mild heart problem, proposed compromise seen as way to dodge the risk while retaining shot's effectiveness
Risks and benefits of vaccinating children against COVID
The EU is scheduled to decide whether to approve vaccination of 12-to-15-year-olds within a few weeks. Not all doctors consider this a good thing.
Alexandra Lützenkirchen, a pediatrician based in the city of Leverkusen in western Germany, will find out on Thursday whether she has good news for her patients. That s when she ll know whether the vaccine doses that she has ordered are going to arrive. We received 24 doses this week for a practice of two, she said. Four vials of the eagerly awaited BioNTech-Pfizer vaccine but we had ordered 24. Right now, we re spending a lot of time postponing appointments.
38 shares
A young Israeli receives a COVID-19 vaccine injection, at a Clalit vaccination center in Holon, February 4, 2021. (Chen Leopold/Flash90)
The Israeli Pediatric Association on Tuesday published a call for parents and family doctors to vaccinate their children when the Pfizer-BioNTech vaccine is approved for those under 16 years old.
The association said it was waiting for regulators to approve the shot. On Friday Pfizer-BioNTech asked for authorization to use its COVID-19 vaccine on 12- to 15-year-olds in the United States.
The letter said the vaccine was safe and effective for children and would help drive down virus rates in the country.